Mindfulness-Based Substance Use Prevention (MINDS-UP)
ConditionSubstance Use
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-14
SponsorNew York State Psychiatric Institute
About this trial
The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The main questions it aims to answer are:
1. Is MINDS-UP feasible and what is its preliminary efficacy? 2. Are MRI protocol and procedures feasible?
An additional exploratory question is:
Are there neural and psychopathological mechanisms through which MINDS-UP might work?
Researchers will compare Sport - Prevention Plus Wellness (PPW) (an evidence based substance use prevention program) to Sport - Prevention Plus Wellness + MINDS-UP to examine the preliminary efficacy of MINDS-UP.
Participants will
* take assessment #1 * have 2 MRIs and take MINDS-UP, just take MINDS-UP or have a delayed start * take assessment #2 * take PPW, a single remote and research assistant-delivered 45-minute session * take assessment #3 * take assessment #4
Eligibility criteria
Qualifiers
Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
Access to a smart phone, tablet, or computer with Wi-Fi
English-speaking
Disqualifiers
Has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
Youth is actively involved in another Boricua Youth Study (BYS)
Youth's sibling is or has previously been enrolled in MINDS-UP.
Trial design
Treatments tested in this trial
- MINDS-UP
- Prevention Plus Wellness
- fMRI
Treatment groups
45 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
New York State Psychiatric Institute
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov